Ottawa, Canada: Canada is starting trials of its experimental Ebola vaccine on a small group of people in the Atlantic port city of Halifax, Health Minister Rona Ambrose announced Friday.
In a statement, she said the vaccine will be tested on 40 people aged 18 to 65 "to assess its safety, determine the appropriate dosage and identify any possible side effects."
Researchers also hope to determine whether lower doses of the VSV-EBOV vaccine induce an immune response in individuals, she said.
The trials coincide with others already underway in the United States at the Walter Reed Army Institute of Research and National Institutes of Health.
Meanwhile 800 doses of the vaccine have been shipped to Switzerland for testing by the World Health Organization (WHO).
There is no licenced treatment or vaccine against Ebola, which has killed more than 5,100 people in the outbreak centered in West Africa.
However, the UN health agency has identified two experimental vaccines that have shown promising results when tested on monkeys: the Canadian VSV-EBOV, licenced by US firm NewLink Genetics, and one made by British company GlaxoSmithKline (GSK).
The WHO said last month it hoped thousands of doses of the vaccines would be ready for use in badly hit African countries by early 2015.
The Canadian trial will be led by the Canadian Immunization Research Network (CIRN).
In a statement, she said the vaccine will be tested on 40 people aged 18 to 65 "to assess its safety, determine the appropriate dosage and identify any possible side effects."
Researchers also hope to determine whether lower doses of the VSV-EBOV vaccine induce an immune response in individuals, she said.
Meanwhile 800 doses of the vaccine have been shipped to Switzerland for testing by the World Health Organization (WHO).
Advertisement
However, the UN health agency has identified two experimental vaccines that have shown promising results when tested on monkeys: the Canadian VSV-EBOV, licenced by US firm NewLink Genetics, and one made by British company GlaxoSmithKline (GSK).
Advertisement
The Canadian trial will be led by the Canadian Immunization Research Network (CIRN).
Advertisement
COMMENTS
Advertisement
Polio First Phase Vaccination Campaign In Gaza Successful: WHO WHO Urges Countries To Accelerate Measures To Reduce Road Traffic Deaths War, Economic Chaos, Extreme Weather Defied Drive To End Hunger In 2023: UN 8 Dead, 2,750 Hurt As Pagers Explode Across Lebanon, Hezbollah Blames Israel Video: Leopard Spotted Crossing Road In Bengaluru's Electronic City IndiGo Flight Tailstrike Leaves Huge Dent During Take-Off From Delhi Airport Sitaram Yechury: CPM Chief, Raconteur And Pragmatic Face Of Left True Secular, Liberal And Feminist: Kangana Ranaut Praises PM Modi Norway Now Has More Electric Cars Than Petrol Models, 1st In The World Track Latest News Live on NDTV.com and get news updates from India and around the world.